Regulators OK first digital pill to track patients
WASHINGTON — U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.
The digital pill approved Monday combines two existing products: the former blockbuster psychiatric medication Abilify, long used to treat schizophrenia and bipolar disorder, with a sensor tracking system first approved in 2012.
Developers Otsuka Pharmaceutical Co. and Proteus Digital Health are likely to face hurdles. The pill has not yet been shown to improve patients’ compliance. Also, patients must be willing to allow caregivers to access the information.